General Mtrs Co Financials
General Mtrs Co (GM) reported $185.0B in revenue for fiscal year 2025, down 1.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
In FY2025, cash generation detached from reported profit, revealing how balance-sheet swings can outweigh margin pressure.
From the prior year, operating margin fell from6.8% to1.6% , a sharp compression on nearly unchanged revenue that points to weaker earnings efficiency rather than a simple sales-volume issue. Yet free cash flow rose to$17.6B as operating cash flow reached$26.9B , showing that cash release and lighter reinvestment outweighed what the income statement alone would suggest.
Over the last three annual periods, the balance sheet stayed liability-heavy, with debt-to-equity rising from 3.2x to 3.6x. Because the current ratio held near 1.1x while cash stayed around the
Over two years, the share count dropped from 1.15B to 904.0M, continuing a sizable reduction in equity outstanding. Even after another buyback year at
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of General Mtrs Co's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
General Mtrs Co has an operating margin of 1.6%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 54/100, indicating healthy but not exceptional operating efficiency. This is down from 6.8% the prior year.
General Mtrs Co's revenue declined 1.3% year-over-year, from $187.4B to $185.0B. This contraction results in a growth score of 45/100.
General Mtrs Co has elevated debt relative to equity (D/E of 3.57), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 17/100, reflecting increased financial risk.
General Mtrs Co's current ratio of 1.17 is below the typical benchmark, resulting in a score of 27/100. This tight liquidity could limit financial flexibility if cash inflows slow.
General Mtrs Co has a free cash flow margin of 9.5%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.
General Mtrs Co's ROE of 4.5% shows moderate profitability relative to equity, earning a score of 52/100. This is down from 9.4% the prior year.
General Mtrs Co scores 1.23, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
General Mtrs Co passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, General Mtrs Co generates $9.66 in operating cash flow ($26.9B OCF vs $2.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
General Mtrs Co generated $185.0B in revenue in fiscal year 2025. This represents a decrease of 1.3% from the prior year.
General Mtrs Co's EBITDA was $14.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 38.6% from the prior year.
General Mtrs Co reported $2.8B in net income in fiscal year 2025. This represents a decrease of 53.4% from the prior year.
General Mtrs Co earned $3.27 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 48.7% from the prior year.
Cash & Balance Sheet
General Mtrs Co generated $17.6B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 88.9% from the prior year.
General Mtrs Co held $20.9B in cash as of fiscal year 2025; long-term debt is not reported for that period.
General Mtrs Co paid $0.57 per share in dividends in fiscal year 2025. This represents an increase of 18.7% from the prior year.
Margins & Returns
General Mtrs Co's operating margin was 1.6% in fiscal year 2025, reflecting core business profitability. This is down 5.3 percentage points from the prior year.
General Mtrs Co's net profit margin was 1.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.7 percentage points from the prior year.
General Mtrs Co's ROE was 4.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.9 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
General Mtrs Co spent $6.0B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 14.9% from the prior year.
General Mtrs Co invested $9.3B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 14.1% from the prior year.
Not reported for fiscal year 2025.
GM Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $185.5B | $185.0B-1.3% | $187.4B+9.1% | $171.8B+9.6% | $156.7B+23.4% | $127.0B+3.7% | $122.5B-10.7% | $137.2B-6.7% | $147.0B+1.0% | $145.6B-2.4% | $149.2B+9.9% | $135.7B-13.0% | $155.9B+0.3% | $155.4B+2.1% | $152.3B+1.3% | $150.3B |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | $100.5B+3.1% | $97.5B-11.8% | $110.7B-8.3% | $120.7B+3.8% | $116.2B-4.6% | $121.8B+7.8% | $113.0B-18.2% | $138.1B+2.3% | $134.9B-3.8% | $140.2B+7.6% | $130.4B |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | $26.5B+6.1% | $24.9B-6.2% | $26.6B+0.7% | $26.4B-10.1% | $29.4B+7.1% | $27.4B+20.5% | $22.7B+27.4% | $17.8B-12.9% | $20.5B+70.6% | $12.0B-39.6% | $19.9B |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $7.2B-2.7% | $7.4B-8.6% | $8.1B |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | $8.6B+21.5% | $7.0B-17.1% | $8.5B-12.0% | $9.7B+0.8% | $9.6B-7.5% | $10.3B-13.0% | $11.9B-2.2% | $12.2B-1.8% | $12.4B-11.8% | $14.0B+15.4% | $12.2B |
| Operating Income | $1.8B | $2.9B-77.2% | $12.8B+37.5% | $9.3B-9.9% | $10.3B+10.6% | $9.3B+40.5% | $6.6B+21.0% | $5.5B+23.3% | $4.4B-48.7% | $8.7B-0.3% | $8.7B+56.8% | $5.5B+262.0% | $1.5B-70.2% | $5.1B+116.9% | -$30.4B-636.8% | $5.7B |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | $4.1B-6.8% | $4.4B+14.0% | $3.9B+23.5% | $3.1B+23.9% | $2.5B+34.6% | $1.9B+3.0% | $1.8B+74.4% | $1.0B+35.9% | $772.0M+3.8% | $744.0M |
| Income Tax | -$6.0M | $338.0M-86.8% | $2.6B+354.0% | $563.0M-70.2% | $1.9B-31.9% | $2.8B+56.2% | $1.8B+130.7% | $769.0M+62.2% | $474.0M-95.9% | $11.5B+321.1% | $2.7B+324.7% | -$1.2B-634.6% | $228.0M-89.3% | $2.1B+106.1% | -$34.8B-31564.5% | -$110.0M |
| Net Income | $2.0B | $2.8B-53.4% | $6.0B-39.4% | $9.8B+1.4% | $9.7B-2.4% | $9.9B+54.7% | $6.4B-4.5% | $6.7B-16.0% | $8.0B+307.4% | -$3.9B-141.0% | $9.4B-2.7% | $9.7B+145.3% | $3.9B-26.1% | $5.3B-13.6% | $6.2B-32.7% | $9.2B |
| EPS (Diluted) | — | $3.27-48.7% | $6.37-13.0% | $7.32+19.4% | $6.13-8.5% | $6.70+54.7% | $4.33-5.3% | $4.57-17.4% | $5.53+312.7% | -$2.60-143.3% | $6.00+1.5% | $5.91+258.2% | $1.65-30.7% | $2.38-18.5% | $2.92-36.2% | $4.58 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
GM Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $281.3B+0.5% | $279.8B+2.5% | $273.1B+3.4% | $264.0B+7.9% | $244.7B+4.0% | $235.2B+3.1% | $228.0B+0.3% | $227.3B+7.0% | $212.5B-4.2% | $221.7B+14.1% | $194.3B+9.6% | $177.3B+6.7% | $166.2B+11.2% | $149.4B+3.3% | $144.6B |
| Current Assets | $108.8B+0.2% | $108.5B+6.8% | $101.6B+1.2% | $100.5B+22.3% | $82.1B+1.5% | $80.9B+7.9% | $75.0B-0.4% | $75.3B+9.5% | $68.7B-9.8% | $76.2B+9.8% | $69.4B-17.0% | $83.6B+2.6% | $81.5B+16.4% | $70.0B+7.8% | $64.9B |
| Cash & Equivalents | $20.9B+5.4% | $19.9B+5.4% | $18.9B-1.6% | $19.2B-4.6% | $20.1B+0.4% | $20.0B+4.8% | $19.1B-8.5% | $20.8B+34.4% | $15.5B+23.4% | $12.6B-17.5% | $15.2B-19.6% | $19.0B-5.3% | $20.0B+8.7% | $18.4B+14.6% | $16.1B |
| Inventory | $14.5B-0.7% | $14.6B-11.5% | $16.5B+7.1% | $15.4B+18.3% | $13.0B+26.9% | $10.2B-1.6% | $10.4B+5.9% | $9.8B-7.9% | $10.7B-3.4% | $11.0B-19.8% | $13.8B+0.9% | $13.6B-2.8% | $14.0B-4.6% | $14.7B+2.7% | $14.3B |
| Accounts Receivable | $13.1B+1.8% | $12.8B+3.6% | $12.4B-7.2% | $13.3B+80.3% | $7.4B-8.0% | $8.0B+18.2% | $6.8B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $1.9B0.0% | $1.9B0.0% | $1.9B0.0% | $1.9B0.0% | $1.9B0.0% | $1.9B0.0% | $1.9B0.0% | $1.9B0.0% | $1.9B0.0% | $1.9B | N/A | $1.4B-8.5% | $1.6B-20.9% | $2.0B-93.2% | $29.0B |
| Total Liabilities | $218.1B+1.8% | $214.2B+4.6% | $204.8B+6.8% | $191.8B+7.2% | $178.9B-3.6% | $185.5B+1.9% | $182.1B-1.3% | $184.6B+4.7% | $176.3B-0.8% | $177.6B+15.3% | $154.0B+8.9% | $141.5B+14.9% | $123.2B+9.6% | $112.4B+6.4% | $105.6B |
| Current Liabilities | $93.3B-3.0% | $96.3B+1.9% | $94.4B+3.6% | $91.2B+22.5% | $74.4B-6.9% | $79.9B-5.9% | $84.9B+3.2% | $82.2B+7.0% | $76.9B-9.7% | $85.2B+19.6% | $71.2B+8.5% | $65.7B+5.2% | $62.4B+15.6% | $54.0B+1.4% | $53.2B |
| Total Equity | $61.1B-3.1% | $63.1B-1.9% | $64.3B-5.2% | $67.8B+13.5% | $59.7B+32.7% | $45.0B+7.7% | $41.8B+7.5% | $38.9B+11.0% | $35.0B-20.2% | $43.8B+9.9% | $39.9B+12.4% | $35.5B-16.8% | $42.6B+17.6% | $36.2B-4.9% | $38.1B |
| Retained Earnings | $51.5B-3.6% | $53.5B-3.5% | $55.4B+12.5% | $49.3B+17.4% | $41.9B+31.2% | $32.0B+19.0% | $26.9B+20.3% | $22.3B+26.6% | $17.6B-32.6% | $26.2B+29.0% | $20.3B+39.2% | $14.6B+5.5% | $13.8B+37.4% | $10.1B+40.0% | $7.2B |
Not reported in any period shown, so not listed: Long-Term Debt.
GM Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $23.2B | $26.9B+33.5% | $20.1B-3.8% | $20.9B+30.5% | $16.0B+5.6% | $15.2B-8.9% | $16.7B+11.0% | $15.0B-1.5% | $15.3B-12.0% | $17.3B+4.3% | $16.6B+41.1% | $11.8B+17.0% | $10.1B-20.3% | $12.6B+19.1% | $10.6B+29.9% | $8.2B |
| Capital Expenditures | $8.8B | $9.3B-14.1% | $10.8B-1.3% | $11.0B+18.7% | $9.2B+23.0% | $7.5B+41.7% | $5.3B-30.2% | $7.6B-13.3% | $8.8B+3.6% | $8.5B+0.8% | $8.4B+23.1% | $6.8B-3.9% | $7.1B-6.3% | $7.6B-6.2% | $8.1B+29.1% | $6.2B |
| Free Cash Flow | $14.4B | $17.6B+88.9% | $9.3B-6.6% | $10.0B+46.4% | $6.8B-11.4% | $7.7B-32.5% | $11.4B+53.0% | $7.4B+14.4% | $6.5B-26.8% | $8.9B+7.9% | $8.2B+65.9% | $5.0B+66.9% | $3.0B-41.4% | $5.1B+99.6% | $2.5B+32.3% | $1.9B |
| Investing Cash Flow | -$8.5B | -$16.1B+21.4% | -$20.5B-39.9% | -$14.7B+18.0% | -$17.9B-9.3% | -$16.4B+25.1% | -$21.8B-100.3% | -$10.9B+47.5% | -$20.8B+24.7% | -$27.6B+22.6% | -$35.6B-28.6% | -$27.7B | N/A | N/A | -$3.5B+72.5% | -$12.7B |
| Financing Cash Flow | -$16.7B | -$9.6B-594.8% | $1.9B+130.5% | -$6.4B-1758.7% | $383.0M-78.0% | $1.7B-68.6% | $5.6B+218.7% | -$4.7B-140.8% | $11.5B-9.0% | $12.6B-26.3% | $17.1B+25.5% | $13.6B | N/A | N/A | -$4.7B-1224.3% | -$358.0M |
| Dividends Paid | $1.2B | $657.0M+0.6% | $653.0M+9.4% | $597.0M+50.4% | $397.0M+113.4% | $186.0M-72.2% | $669.0M-71.5% | $2.4B+4.8% | $2.2B+0.4% | $2.2B-5.7% | $2.4B+5.6% | $2.2B-29.2% | $3.2B+87.6% | $1.7B+79.7% | $939.0M+2.5% | $916.0M |
| Share Buybacks | $6.8B | $6.0B-14.9% | $7.1B-36.4% | $11.1B+344.6% | $2.5B | $0-100.0% | $90.0M | $0-100.0% | $190.0M-95.8% | $4.5B+79.7% | $2.5B-29.0% | $3.5B+7.4% | $3.3B+34.4% | $2.4B-52.2% | $5.1B | $0 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
GM Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | 20.8%+0.5pp | 20.4%+1.0pp | 19.4%+1.4pp | 17.9%-2.2pp | 20.2%+1.8pp | 18.4%+1.6pp | 16.8%+5.3pp | 11.5%-1.7pp | 13.2%+5.3pp | 7.9%-5.3pp | 13.2% |
| Operating Margin | 1.6%-5.3pp | 6.8%+1.4pp | 5.4%-1.2pp | 6.6%-0.8pp | 7.3%+1.9pp | 5.4%+1.4pp | 4.0%+1.0pp | 3.0%-2.9pp | 5.9%+0.1pp | 5.8%+1.7pp | 4.1%+3.1pp | 1.0%-2.3pp | 3.3%+23.2pp | -19.9%-23.7pp | 3.8% |
| Net Margin | 1.5%-1.7pp | 3.2%-2.5pp | 5.7%-0.5pp | 6.2%-1.6pp | 7.8%+2.6pp | 5.3%+0.3pp | 4.9%-0.5pp | 5.5%+8.1pp | -2.6%-9.0pp | 6.3%-0.8pp | 7.1%+4.6pp | 2.5%-0.9pp | 3.4%-0.6pp | 4.1%-2.1pp | 6.1% |
| Return on Equity | 4.5%-4.9pp | 9.4%-5.9pp | 15.3%+1.0pp | 14.3%-2.3pp | 16.7%+2.4pp | 14.3%-1.8pp | 16.1%-4.5pp | 20.6%+31.7pp | -11.0%-32.6pp | 21.5%-2.8pp | 24.3%+13.2pp | 11.1%-1.4pp | 12.6%-4.5pp | 17.1%-7.0pp | 24.1% |
| Return on Assets | 1.0%-1.1pp | 2.1%-1.5pp | 3.6%-0.1pp | 3.7%-0.4pp | 4.1%+1.3pp | 2.7%-0.2pp | 2.9%-0.6pp | 3.5%+5.3pp | -1.8%-6.1pp | 4.3%-0.7pp | 5.0%+2.7pp | 2.2%-1.0pp | 3.2%-0.9pp | 4.1%-2.2pp | 6.4% |
| Current Ratio | 1.170.0x | 1.13+0.1x | 1.080.0x | 1.100.0x | 1.10+0.1x | 1.01+0.1x | 0.880.0x | 0.920.0x | 0.890.0x | 0.89-0.1x | 0.97-0.3x | 1.270.0x | 1.310.0x | 1.30+0.1x | 1.22 |
| Debt-to-Equity | 3.57+0.2x | 3.40+0.2x | 3.19+0.4x | 2.83-0.2x | 2.99-1.1x | 4.12-0.2x | 4.36-0.4x | 4.75-0.3x | 5.04+1.0x | 4.05+0.2x | 3.86-0.1x | 3.99+1.1x | 2.89-0.2x | 3.10+0.3x | 2.77 |
| FCF Margin | 9.5%+4.5pp | 5.0%-0.8pp | 5.8%+1.5pp | 4.3%-1.7pp | 6.0%-3.2pp | 9.3%+3.9pp | 5.4%+1.0pp | 4.4%-1.7pp | 6.1%+0.6pp | 5.5%+1.9pp | 3.6%+1.7pp | 1.9%-1.4pp | 3.3%+1.6pp | 1.7%+0.4pp | 1.3% |
Similar Companies
Where General Mtrs Co Ranks
Frequently Asked Questions
What is General Mtrs Co's annual revenue?
General Mtrs Co (GM) reported $185.0B in total revenue for fiscal year 2025. This represents a -1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is General Mtrs Co's revenue growing?
General Mtrs Co (GM) revenue declined by 1.3% year-over-year, from $187.4B to $185.0B in fiscal year 2025.
Is General Mtrs Co profitable?
Yes, General Mtrs Co (GM) reported a net income of $2.8B in fiscal year 2025, with a net profit margin of 1.5%.
What is General Mtrs Co's EBITDA?
General Mtrs Co (GM) had EBITDA of $14.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is General Mtrs Co's operating margin?
General Mtrs Co (GM) had an operating margin of 1.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is General Mtrs Co's net profit margin?
General Mtrs Co (GM) had a net profit margin of 1.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does General Mtrs Co pay dividends?
Yes, General Mtrs Co (GM) paid $0.57 per share in dividends during fiscal year 2025.
What is General Mtrs Co's return on equity (ROE)?
General Mtrs Co (GM) has a return on equity of 4.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is General Mtrs Co's free cash flow?
General Mtrs Co (GM) generated $17.6B in free cash flow during fiscal year 2025. This represents a 88.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is General Mtrs Co's operating cash flow?
General Mtrs Co (GM) generated $26.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are General Mtrs Co's total assets?
General Mtrs Co (GM) had $281.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are General Mtrs Co's capital expenditures?
General Mtrs Co (GM) invested $9.3B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is General Mtrs Co's current ratio?
General Mtrs Co (GM) had a current ratio of 1.17 as of fiscal year 2025, which is considered adequate.
What is General Mtrs Co's debt-to-equity ratio?
General Mtrs Co (GM) had a debt-to-equity ratio of 3.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is General Mtrs Co's return on assets (ROA)?
General Mtrs Co (GM) had a return on assets of 1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is General Mtrs Co's Altman Z-Score?
General Mtrs Co (GM) has an Altman Z-Score of 1.23, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is General Mtrs Co's Piotroski F-Score?
General Mtrs Co (GM) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are General Mtrs Co's earnings high quality?
General Mtrs Co (GM) has an earnings quality ratio of 9.66x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is General Mtrs Co?
General Mtrs Co (GM) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.